These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 24144036)
1. TGF-β1 signal pathway in the regulation of inflammation in patients with atrial fibrillation. Mira YE; Muhuyati ; Lu WH; He PY; Liu ZQ; Yang YC Asian Pac J Trop Med; 2013 Dec; 6(12):999-1003. PubMed ID: 24144036 [TBL] [Abstract][Full Text] [Related]
2. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation. Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263 [TBL] [Abstract][Full Text] [Related]
3. The Impact of Transforming Growth Factor-β Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T J Cardiovasc Electrophysiol; 2017 Apr; 28(4):402-409. PubMed ID: 28127812 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation. Li Y; Jian Z; Yang ZY; Chen L; Wang XF; Ma RY; Xiao YB Cardiology; 2013; 124(4):233-40. PubMed ID: 23571482 [TBL] [Abstract][Full Text] [Related]
5. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation. Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation. Zhao F; Zhang S; Chen Y; Gu W; Ni B; Shao Y; Wu Y; Qin J BMC Cardiovasc Disord; 2014 Nov; 14():167. PubMed ID: 25422138 [TBL] [Abstract][Full Text] [Related]
7. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation. Zhang D; Chen X; Wang Q; Wu S; Zheng Y; Liu X PLoS One; 2017; 12(3):e0173759. PubMed ID: 28323847 [TBL] [Abstract][Full Text] [Related]
8. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease. Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599 [TBL] [Abstract][Full Text] [Related]
9. The potential regulatory role of hsa_circ_0004104 in the persistency of atrial fibrillation by promoting cardiac fibrosis via TGF-β pathway. Gao Y; Liu Y; Fu Y; Wang Q; Liu Z; Hu R; Yang X; Chen M BMC Cardiovasc Disord; 2021 Jan; 21(1):25. PubMed ID: 33421993 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid ameliorates early cardiac dysfunction after coronary microembolization and suppresses TGF-β1/Smad3 and CTGF expression. Chen Z; Qian J; Ma J; Chang S; Yun H; Jin H; Sun A; Zou Y; Ge J Int J Cardiol; 2013 Sep; 167(5):2278-84. PubMed ID: 22727959 [TBL] [Abstract][Full Text] [Related]
12. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts. Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633 [TBL] [Abstract][Full Text] [Related]
13. TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease. Sun Y; Huang ZY; Wang ZH; Li CP; Meng XL; Zhang YJ; Su F; Ma N Mol Cell Biochem; 2015 Aug; 406(1-2):131-8. PubMed ID: 25971370 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation. Sasaki N; Okumura Y; Watanabe I; Mano H; Nagashima K; Sonoda K; Kogawa R; Ohkubo K; Nakai T; Hirayama A J Interv Card Electrophysiol; 2014 Apr; 39(3):241-9. PubMed ID: 24554250 [TBL] [Abstract][Full Text] [Related]
15. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy. Canpolat U; Oto A; Hazirolan T; Sunman H; Yorgun H; Şahiner L; Kaya EB; Aytemir K J Cardiovasc Electrophysiol; 2015 Mar; 26(3):251-9. PubMed ID: 25366936 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-17A contributes to the development of post-operative atrial fibrillation by regulating inflammation and fibrosis in rats with sterile pericarditis. Fu XX; Zhao N; Dong Q; Du LL; Chen XJ; Wu QF; Cheng X; Du YM; Liao YH Int J Mol Med; 2015 Jul; 36(1):83-92. PubMed ID: 25955429 [TBL] [Abstract][Full Text] [Related]
17. TGF-β1/Smad3 Signaling Pathway Suppresses Cell Apoptosis in Cerebral Ischemic Stroke Rats. Zhu H; Gui Q; Hui X; Wang X; Jiang J; Ding L; Sun X; Wang Y; Chen H Med Sci Monit; 2017 Jan; 23():366-376. PubMed ID: 28110342 [TBL] [Abstract][Full Text] [Related]
18. Frequency of vacuolating cytotoxin A (VacA)-positive Helicobacter pylori seropositivity and TGF-β1 decrease in atrial fibrillation. Ki MR; Shin DG; Park JS; Hong KS; Hong IH; Park JK; Jeong KS Int J Cardiol; 2010 Nov; 145(2):345-346. PubMed ID: 20034688 [TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-Gallate Inhibits Atrial Fibrosis and Reduces the Occurrence and Maintenance of Atrial Fibrillation and its Possible Mechanisms. Li T; Tong Q; Wang Z; Yang Z; Sun Y; Cai J; Xu Q; Lu Y; Liu X; Lin K; Qian Y Cardiovasc Drugs Ther; 2024 Oct; 38(5):895-916. PubMed ID: 37000367 [TBL] [Abstract][Full Text] [Related]
20. Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway. Gramley F; Lorenzen J; Koellensperger E; Kettering K; Weiss C; Munzel T Int J Cardiol; 2010 Sep; 143(3):405-13. PubMed ID: 19394095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]